Unintended consequences of therapy in the intensive care unit

JAMA Intern Med. 2014 Apr;174(4):574-6. doi: 10.1001/jamainternmed.2013.13509.

Authors

Richard Kim¹, Christopher H Goss²

Affiliations

¹ Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington, Seattle.
² Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington, Seattle2Division of Pulmonary Medicine, Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington.

PMID: 24534847
DOI: 10.1001/jamainternmed.2013.13509

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.
Comment

MeSH terms

Critical Illness*
Female
Gastrointestinal Hemorrhage / prevention & control*
Histamine H2 Antagonists / therapeutic use*
Humans
Intensive Care Units*
Male
Proton Pump Inhibitors / therapeutic use*

Substances

Histamine H2 Antagonists
Proton Pump Inhibitors

Grants and funding